Dr. Mesa on Incorporating MPN Guidelines into Clinical Practice

Ruben A. Mesa, MD, chair of Hematology, Mayo Clinic, discusses how community oncologists can incorporate the NCCN Guideline for Myeloproliferative Neoplasms (MPNs) into clinical practice.

Mesa hopes that the guidelines will be useful to physicians who are treating patients with MPNs. Moreover, he recognizes that trying to keep track of the various hematologic malignancies and their corresponding therapies are very challenging. The guidelines aim to help guide physicians during key decision points during treatment.

In patients for whom there is uncertainty as to which therapy they should receive, the guidelines can be a useful tool. For those who are on the fence with transplantation, discussing ideas with other physicians can be beneficial, Mesa adds.